Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Abiomed Inc (ABMD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 10,094,984
  • Shares Outstanding, K 44,220
  • Annual Sales, $ 445,300 K
  • Annual Income, $ 52,120 K
  • 36-Month Beta 0.15
  • Price/Sales 22.43
  • Price/Cash Flow 168.65
  • Price/Book 16.51

Price Performance

See More
Period Period Low Period High Performance
1-Month
187.01 +21.98%
on 12/29/17
229.43 -0.58%
on 01/22/18
+36.47 (+19.03%)
since 12/22/17
3-Month
164.80 +38.42%
on 10/25/17
229.43 -0.58%
on 01/22/18
+53.49 (+30.63%)
since 10/20/17
52-Week
103.53 +120.33%
on 02/02/17
229.43 -0.58%
on 01/22/18
+116.27 (+103.96%)
since 01/20/17

Most Recent Stories

More News
Abiomed Hits New 52-Week High: 3 Factors Driving the Stock

Abiomed (ABMD) recently reported strong preliminary third-quarter fiscal 2018 results.

ITGR : 49.23 (+0.37%)
ABMD : 228.09 (-0.09%)
BIO : 253.05 (-0.59%)
ISRG : 429.07 (-0.96%)
Wright Medical Upbeat on Preliminary Q4 & 2017 Sales Results

Wright Medical (WMGI) forecasts improved sales, despite a plunge in revenues generated from the lower extremities business in fourth-quarter fiscal 2017.

WMGI : 23.00 (-0.26%)
ABMD : 228.09 (-0.09%)
BIO : 253.05 (-0.59%)
CNC : 111.40 (+0.66%)
Phibro (PAHC) Strong on Animal Health Arm, Dull MFA Ails

Phibro's (PAHC) Animal Health segment has been a key contributor to growth over the last few quarters. MFA remains soft in the United States due to sales decline of medically important antimicrobials.

ABMD : 228.09 (-0.09%)
PAHC : 36.05 (-0.41%)
BIO : 253.05 (-0.59%)
CNC : 111.40 (+0.66%)
NANO Arm Profits for Bruker, MERLIN Buyout Holds Promise

Bruker's (BRKR) latest MERLIN buyout is likely to complement its MALDI Biotyper platform. Also, NANO Surfaces group business realizes profitability owing to prior restructuring and cost actions.

TCMD : 30.67 (-1.54%)
ABMD : 228.09 (-0.09%)
BRKR : 35.00 (-0.57%)
ISRG : 429.07 (-0.96%)
RTI Surgical (RTIX) to Acquire Zyga, Improve Spine Surgeries

RTI Surgical (RTIX) to integrate Zyga's SImmetry Sacroiliac Joint Fusion System to diversify Spine franchise.

TCMD : 30.67 (-1.54%)
ABMD : 228.09 (-0.09%)
RTIX : 4.45 (unch)
ISRG : 429.07 (-0.96%)
FDA Nod for Zimmer Biomet's Sidus, Aids Arthroplasty Arm

Zimmer Biomet's (ZBH) Sidus Stem-Free Shoulder system offers a minimal bone resection in total shoulder arthroplasty, which the company claims to help reduce pain and restore a range of motions.

TCMD : 30.67 (-1.54%)
ZBH : 124.72 (+1.00%)
ABMD : 228.09 (-0.09%)
ISRG : 429.07 (-0.96%)
Abiomed Announces Preliminary Q3 FY 2018 Revenue of $154 Million, Up 34% Over Prior Year

Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support technologies, today reported preliminary, unaudited, third quarter fiscal 2018 revenue of approximately $154 million, an increase...

ABMD : 228.09 (-0.09%)
AngioDynamics (ANGO) Misses on Earnings, Revenues in Q2

Dwindling revenues in two major segments hurt AngioDynamics' (ANGO) second-quarter results.

ITGR : 49.23 (+0.37%)
ABMD : 228.09 (-0.09%)
BSX : 27.17 (-1.74%)
ANGO : 16.55 (-1.31%)
Abiomed Inc Set to Possibly Pullback After Yesterday's Rally of 1.31%

Abiomed Inc (NASDAQ:ABMD) traded in a range yesterday that spanned from a low of $200.78 to a high of $202.06. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of...

ABMD : 228.09 (-0.09%)
New Strong Buy Stocks for January 4th

New Strong Buy Stocks for January 4th

SCHN : 35.45 (-4.70%)
ABMD : 228.09 (-0.09%)
FII : 34.36 (-0.49%)
DCI : 51.34 (-1.61%)
RDN : 23.02 (-0.73%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More

Business Summary

Abiomed, Inc., is a leading developer, manufacturer and marketer of medical products designed to assist or replace the pumping function of the failing heart. Abiomed currently manufactures and sells the AB5000 Circulatory Support System and the BVS 5000 Biventricular Support System for the temporary...

See More

Key Turning Points

2nd Resistance Point 230.77
1st Resistance Point 229.53
Last Price 228.09
1st Support Level 226.57
2nd Support Level 224.85

See More

52-Week High 229.43
Last Price 228.09
Fibonacci 61.8% 181.34
Fibonacci 50% 166.48
Fibonacci 38.2% 151.62
52-Week Low 103.53

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.